Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

An investigation into cellular components in bacteria has unexpectedly uncovered a feature with relevance across many life ...

In the dim waters off the Japanese coast, scientists have stumbled upon something that shouldn’t exist. Or at least not by ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

High-resolution imaging has revealed the internal layout of chromatin condensates, showing how DNA fibers fold and interact ...

The United States DNA polymerase market is projected to reach USD 246.9 million by 2035, supported by rising investments in ...